From First-Line Failure to Targeted Care: Expert Guidance on Optimized Treatment for Patients with Chronic GVHD
Wed, Aug 12
|Maggiano's Little Italy
Time & Location
Aug 12, 2026, 6:15 PM – 7:30 PM
Maggiano's Little Italy, 4 Columbus Ave, Boston, MA 02116, USA
About The Event
Join the Boston Chapter for a wonderful dinner presentation for 1.0 FREE ANCC contact hours!

PROGRAM OVERVIEW
The education program is designed to enhance health care professionals’ ability to assess the mechanisms and clinical evidence surrounding both current and emerging targeted therapies for chronic graft-versus-host disease (cGVHD). It focuses on implementing best practices for selecting and sequencing treatments, as well as effectively incorporating targeted therapies into clinical routines. Additionally, the program emphasizes the importance of a multidisciplinary approach to supportive care, ensuring that referrals, clinical symptoms, and treatment-related side effects in cGVHD are managed collaboratively.
TARGET AUDIENCE
The intended audience for this activity is transplant specialists, hematologists, oncologists, and other health care professionals involved in the treatment of patients with cGVHD.
